Difelikefalin, a peripherally restricted, selective kappa opioid receptor agonist, relieved moderate to severity itching in patients with stage 3 to 5 CKD significantly better than placebo in a phase 2 trial.
Many healthcare workers on the front lines of the COVID-19 pandemic lack the needed patient-protective equipment, putting them at the highest risk of contracting the disease, Holly Kramer, MD, President of the National Kidney Foundation (NKF), said in a March 26 address to attendees of the organization’s first live-virtual Spring Clinical Meetings. “At no other…
Many CKD patients are unaware of Medicare benefits for medical nutrition therapy.
Veverimer treats metabolic acidosis by binding and eliminating hydrochloric acid from the gastrointestinal tract without introducing unwanted sodium or potassium.
Transfusion risk reduction appeared greater in nondialysis than dialysis patients taking roxadustat, data show.
In a study of dialysis patients, higher interleukin 6 levels correlated with higher Agatston calcium scores and mortality risk.
More research is needed on diabetes-dependent eGFR decline, according to investigators.
In diabetic patients with chronic kidney disease and metabolic acidosis, veverimer resulted in significantly greater improvement in serum bicarbonate levels at 52 weeks compared with placebo.
Patients with active lupus nephritis who received voclosporin experienced a superior renal response as patients receiving standard of care.
Investigators report encouraging results from a novel protocol that omits intravenous hydration following iodine contrast imaging studies.
As part of its first live-virtual Spring Clinical Meetings, the National Kidney Foundation (NKF) today is presenting awards to specialists in nephrology “who most exemplify the relentless efforts of the foundation to enhance the lives of patients through action, education and accelerating change,” according to a press release issued by the organization. Here is a…
After implementation of the federal prospective payment system for dialysis services in 2011, use of thrombolytic agents declined within HD units but increased outside of HD units, a study found.
More autosomal dominant polycystic kidney disease patients at risk of rapid progression reside in the Southern US.
Improvement in serum bicarbonate was associated with decreased risk of death.
A proportion of patients with CKD and hyperkalemia have metabolic acidosis.